Clinical Trial Update: A Study to Evaluate MIV-818 in Patients With Liver Cancer Manifestations [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating MIV-818 in liver cancer manifestations (hepatocellular carcinoma and intrahepatic cholangiocarcinoma) has been u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Intrahepatic Cholangiocarcinoma
• Liver Metastases

Drugs mentioned

• MIV-818 (MIV-818)

Snippet

Sponsor: Medivir | Conditions: Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma | Phase 1, Phase 2 | Status: COMPLETED